Víctor Monforte Selected Research

Víctor Monforte Research Topics

3	Bronchiolitis Obliterans Syndrome 01/2022 - 05/2003
3	Pulmonary Hypertension 01/2018 - 12/2006
3	Aspergillosis 05/2010 - 05/2003
2	Venous Thromboembolism 12/2017 - 04/2015
2	Cystic Fibrosis (Mucoviscidosis) 06/2014 - 02/2014
1	Disease Progression 01/2021
1	Infections 01/2021
1	COVID-19 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018
1	Systemic Scleroderma (Systemic Sclerosis) 01/2018
1	Emphysema 08/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2015
1	Cytomegalovirus Infections (Inclusion Disease) 04/2015
1	Pulmonary Embolism 04/2015
1	Venous Thrombosis (Deep-Vein Thrombosis) 04/2015
1	Thrombophilia 04/2015
1	Bronchiolitis 12/2011
1	Mycoses (Diseases, Fungus) 12/2011
1	Thromboembolism 01/2009
1	Tuberculosis (Tuberculoses) 01/2005

3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 06/2014
2	Cytisus-type anti-H(O) lectins (CSA-I)IBA 01/2022 - 01/2022
2	liposomal amphotericin B FDA Link 05/2010 - 02/2009
2	Amphotericin B (Amphotericin)FDA LinkGeneric 02/2009 - 05/2003
1	Enoxaparin (Lovenox)FDA LinkGeneric 12/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2015
1	Calcineurin InhibitorsIBA 04/2015
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2014
1	deoxycholate drug combination amphotericin BIBA 05/2010
1	Bosentan (Tracleer)FDA Link 12/2006
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2005
1	Technetium (Technetium 99m)IBA 05/2003